QMS Everolimus Immunoassay

GUDID 00884883011687

Microgenics Corporation

Rapamycin (sirolimus) therapeutic drug monitoring IVD, reagent
Primary Device ID00884883011687
NIH Device Record Key57c98f67-dd51-40e4-a00c-1f00f2aae525
Commercial Distribution StatusIn Commercial Distribution
Brand NameQMS Everolimus Immunoassay
Version Model Number0380000
Company DUNS122153799
Company NameMicrogenics Corporation
Device Count1
DM Exemptfalse
Pre-market Exemptfalse
MRI Safety StatusLabeling does not contain MRI Safety Information
Human Cell/Tissue Productfalse
Device Kitfalse
Device Combination Productfalse
Single Usetrue
Lot Batchtrue
Serial Numberfalse
Manufacturing Datefalse
Expiration Datetrue
Donation Id Numberfalse
Contains Natural Rubber Latexfalse
Labeled No Natural Rubber Latexfalse
RX Perscriptionfalse
OTC Over-The-Counterfalse

Device Identifiers

Device Issuing AgencyDevice ID
GS100884883011687 [Primary]

FDA Product Code

OUFEverolimus Immunoassay

Sterilization

Steralize Prior To Usefalse
Device Is Sterilefalse

Device Entry Metadata

Public Version StatusUpdate
Device Record StatusPublished
Public Version Number2
Public Version Date2018-03-29
Device Publish Date2016-09-21

On-Brand Devices [QMS Everolimus Immunoassay]

008848830116870380000
008848830005370380005

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.